bioAffinity
  • Home
  • Publications
  • News
  • About
  • Contact
  • Investor Relations
Select Page

Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning

by Dale Harrison | Jan 23, 2023 | Publications

Respiratory Research, January 21, 2023   Authors Lemieux, M.E., Reveles, X.T., Rebeles, J. et al. Abstract Background Low-dose spiral computed tomography (LDCT) may not lead to a clear treatment path when small to intermediate-sized lung nodules are identified....

Reassessing Cobalamin Requirements in Cell Culture

by Dale Harrison | Dec 1, 2022 | Publications

Cell Bio, a joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO), in Washington, D.C., on Dec. 3-7, 2022. AuthorsDavid J. Elzi, Reggie Jacob, and Vivienne I. Rebel Introduction Cobalamin (Vitamin B12) is an...

Sputum analysis by flow cytometry; an effective platform to analyze the lung environment

by Dale Harrison | Aug 17, 2022 | Publications

“Sputum analysis by flow cytometry; an effective platform to analyze the lung environment” PLoS ONE – August 17, 2022   Authors Bederka L.H., Sanchez JR, Rebeles J, Araujo PR, Grayson MH, Lai S-C, et al.   Abstract Low-dose computed tomography...

Quality-Controlled Sputum Analysis by Flow Cytometry

by Dale Harrison | Jul 28, 2021 | Publications

“Quality-Controlled Sputum Analysis by Flow Cytometry” Journal of Visualized Experiments (JoVE) – August 9, 2021   Authors Marcia Grayson, Shao-Chiang Lai, Lydia H. Bederka, Patricia Araujo, Jamila Sanchez, Xavier T. Reveles, Vivienne I. Rebel,...

Meso-tetra (4-carboMeso-tetra (4-carboxyphenyl) Porphyrin (TCPP) is taken up in Cancer Cells by the CD320 Receptor

by Dale Harrison | Jul 2, 2021 | Publications

“Meso-tetra (4-carboMeso-tetra (4-carboxyphenyl) porphyrin (TCPP) is taken up in cancer cells by the CD320 receptor” International Conference on Porphyrins and Phthalocyanines (ICPP) ICPP-11, June 26 through July 2, 2021   Authors David J. Elzi, William E. Bauta,...

Selective Cancer Cell Killing by Dual siRNA Knockdown of CD320 and LRP2 Receptors

by Dale Harrison | Jun 25, 2021 | Publications

“Selective Cancer Cell Killing by Dual siRNA Knockdown of CD320 and LRP2 Receptors” RNA Therapeutics Institute’s 2021 RNA Therapeutics Symposium at the University of Massachusetts Medical School June 23 – 25, 2021   Authors David J. Elzi, William E. Bauta,...
« Older Entries

Categories

  • Articles (17)
  • Events (35)
  • News (42)
  • Press Releases (60)
  • Publications (15)

Recent Posts

  • bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results March 31, 2023
  • bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer March 28, 2023
  • bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023 March 23, 2023
  • bioAffinity Technologies CEO Maria Zannes Shares CyPath®Lung with The Empowered Patient Podcast March 6, 2023
  • bioAffinity CEO To Moderate Health Cell Panel on Resources for Start-Ups March 6, 2023

Learn About CyPath Lung

CyPath Lung Test

Main Menu

  • Home
  • Publications
  • News
  • About
  • Contact
  • Investor Relations
Copyright © 2023 bioAffinity Technologies, Inc.